Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Marker Gene Technologies, Inc”

6 pharma patents match "Marker Gene Technologies, Inc" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 6
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 6 pharmaceutical patents matching "Marker Gene Technologies, Inc" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

6 results for “Marker Gene Technologies, Inc” · 30,257 patents in full index Clear search

  1. US 10543282

    Targeted peptide conjugates

    Marker Gene Technologies, Inc · Granted Jan 28, 2020 · Expires Jan 23, 2040

    granted
  2. US 10401361

    Intracellular organelle peptide targeted enzyme substrates

    Marker Gene Technologies, Inc · Granted Sep 3, 2019 · Expires Aug 29, 2039

    granted
  3. US 9925271

    Targeted pharmacological chaperones

    Marker Gene Technologies, Inc · Granted Mar 27, 2018 · Expires Mar 22, 2038

    granted
  4. US 9841426

    Intracellular organelle peptide targeted enzyme substrates

    Marker Gene Technologies, Inc · Granted Dec 12, 2017 · Expires Dec 7, 2037

    granted
  5. US 9610358

    Targeted pharmacological chaperones

    Marker Gene Technologies, Inc · Granted Apr 4, 2017 · Expires Mar 30, 2037

    granted
  6. US 6656917

    Compositions and methods for targeted enzymatic release of cell regulatory compounds

    Marker Gene Technologies, Inc · Granted Dec 2, 2003 · Expires Nov 27, 2023

    expired